Anti-inflammatory |
Down-regulates activity of COX-2, lipoxygenase and inducible iNOS enzymes |
Inhibits production of TNF-alpha, IL-1, -2, -6, -8, and -12, MCP, migration inhibitory protein |
Down-regulates mitogen-activated and Janus kinases |
Anti-neoplastic via cell-cycle arrest |
Inhibits expression of cyclin D1 and CDK4 via acetylation and upregulation of p53 |
ATP-competitive inhibitor by down-regulating mRNA & protein expression of cyclin D1 |
Induction of CDK inhibitors p16(/INK4a), p21(/WAF1/CIP1), and p27(/KIP1) |
Inhibits cyclin E/cyclin D1 expression |
Hyperphosphorylation of retinoblastoma (Rb) protein (CDK2 substrate) |
Induction of apoptotic signals |
Induced upregulation of Fas, FasL, and DR5 expression |
Enhances cleavage of procaspases and poly(ADP-ribose) polymerase |
Upregulates the expression of DR 4 and 5 |
Inhibits the TNF-α-induced production of IL-6/IL-8 in HaCaT cells |
p38-dependent upregulation of FasL in Huh7 cells |
Inhibits TNF-α-induced activation of NF-κB, including NF-κB-P65 |